title: Restraint-induced modulation of allergic and irritant contact dermatitis in male and female B6.129 mice.
abstract: Recent studies in rats have indicated that acute restraint enhances cutaneous hypersensitivity. We hypothesized that acute restraint would also modulate the development of allergic and irritant dermatitis in mice and that these restraint-induced changes would be reflected in the cutaneous cytokine profile and be gender-specific. For these studies, male and female B6.129 mice were sensitized and challenged with the contact sensitizer dinitrofluorobenzene or challenged with the irritant croton oil. Two-hour restraint was applied prior to chemical challenge. Restraint combined with chemical increased ear swelling in both genders in ACD, a change that was blocked by administration of RU-486 prior to restraint. Neither restraint nor RU-486 administration modulated development of ICD; however, IL-1beta was decreased by restraint in females only. TNF-alpha and IFN-gamma production were modified in ACD; TNF-alpha in both genders and IFN-gamma in female mice only. Our data demonstrate that acute restraint increases serum corticosterone in B6.129 male and female mice to comparable levels. Restraint modulated the murine ear swelling in ACD, but not ICD, in both genders, and the change in the ear swelling response and cytokine production were, at least in part, corticosterone-dependent.
authors: Toxicology and Molecular Biology Branch, Centers for Disease Control and Prevention, Morgantown, West Virginia, 26505, USA.
authors: M S
authors: MS
authors: Flint
authors: D B
authors: DB
authors: Miller
authors: S S
authors: SS
authors: Tinkle
mesh_terms: D000818:Animals; D003345:Corticosterone / Q000097:blood / Q000276:immunology; D003436:Croton Oil; D017449:Dermatitis, Allergic Contact / Q000276:immunology*; D017453:Dermatitis, Irritant / Q000276:immunology*; D003879:Dermatologic Agents; D004139:Dinitrofluorobenzene; D004431:Ear, External; D004487:Edema / Q000139:chemically induced / Q000276:immunology; D005260:Female; D006727:Hormone Antagonists / Q000494:pharmacology; D007371:Interferon-gamma / Q000096:biosynthesis / Q000097:blood / Q000276:immunology; D007375:Interleukin-1 / Q000096:biosynthesis / Q000097:blood / Q000276:immunology; D007509:Irritants; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D015735:Mifepristone / Q000494:pharmacology; D015213:Neuroimmunomodulation / Q000187:drug effects / Q000276:immunology; D012149:Restraint, Physical; D012737:Sex Factors; D013312:Stress, Physiological / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis / Q000276:immunology
chemical_list: D003879:Dermatologic Agents; D006727:Hormone Antagonists; D007375:Interleukin-1; D007509:Irritants; D014409:Tumor Necrosis Factor-alpha; D015735:Mifepristone; D003436:Croton Oil; D007371:Interferon-gamma; D004139:Dinitrofluorobenzene; D003345:Corticosterone